{"id":"https://openalex.org/W44938027","doi":null,"title":"Targeted therapy for thyroid cancer: An updated review of investigational agents.","display_name":"Targeted therapy for thyroid cancer: An updated review of investigational agents.","publication_year":2010,"publication_date":"2010-06-01","ids":{"openalex":"https://openalex.org/W44938027","mag":"44938027","pmid":"https://pubmed.ncbi.nlm.nih.gov/20496261"},"language":"en","primary_location":{"id":"pmid:20496261","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20496261","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061066852","display_name":"Hari Anant Deshpande","orcid":"https://orcid.org/0000-0003-0697-9355","observed_orcids":["https://orcid.org/0000-0003-0697-9355"]},"institutions":[{"id":"https://openalex.org/I2802730090","display_name":"Yale Cancer Center","ror":"https://ror.org/03j7sze86","country_code":"US","type":"facility","lineage":["https://openalex.org/I2802730090","https://openalex.org/I4210117499","https://openalex.org/I4210165192"]},{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hari A Deshpande","raw_affiliation_strings":["Yale Cancer Center, 333 Cedar Street, FMP 124, New Haven, CT 06520, USA. hari.deshpande@yale.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale Cancer Center, 333 Cedar Street, FMP 124, New Haven, CT 06520, USA. hari.deshpande@yale.edu","institution_ids":["https://openalex.org/I2802730090","https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070967174","display_name":"Scott N. Gettinger","orcid":"https://orcid.org/0000-0003-0886-6880","observed_orcids":["https://orcid.org/0000-0003-0886-6880"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott N Gettinger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5039439529","display_name":"Julie Ann Sosa","orcid":"https://orcid.org/0000-0002-3356-7316","observed_orcids":["https://orcid.org/0000-0002-3356-7316"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julie A Sosa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7767,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.73063591,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"11","issue":"6","first_page":"661","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10329","display_name":"Thyroid Cancer Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11728","display_name":"Thyroid and Parathyroid Surgery","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10293","display_name":"Thyroid Disorders and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thyroid-cancer","display_name":"thyroid cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.9980000257492065},{"id":"https://openalex.org/keywords/vegfr","display_name":"VEGFR","score":0.6850000023841858},{"id":"https://openalex.org/keywords/braf","display_name":"BRAF","score":0.9909999966621399},{"id":"https://openalex.org/keywords/ret","display_name":"RET","score":0.9940000176429749},{"id":"https://openalex.org/keywords/papillary-thyroid-carcinoma","display_name":"papillary thyroid carcinoma","score":0.8700000047683716},{"id":"https://openalex.org/keywords/medullary-thyroid-carcinoma","display_name":"medullary thyroid carcinoma","score":1.0},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.996999979019165},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":1.0},{"id":"https://openalex.org/keywords/vandetanib","display_name":"vandetanib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/investigational-agents","display_name":"investigational agents","score":0.5979999899864197},{"id":"https://openalex.org/keywords/carcinogenesis-mechanisms","display_name":"carcinogenesis mechanisms","score":0.7940000295639038}],"concepts":[{"id":"https://openalex.org/C2780333294","wikidata":"https://www.wikidata.org/wiki/Q7914515","display_name":"Vandetanib","level":4,"score":0.9631558656692505},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8685628175735474},{"id":"https://openalex.org/C2780120053","wikidata":"https://www.wikidata.org/wiki/Q3493538","display_name":"Medullary thyroid cancer","level":4,"score":0.8309136629104614},{"id":"https://openalex.org/C2779761222","wikidata":"https://www.wikidata.org/wiki/Q826522","display_name":"Thyroid cancer","level":3,"score":0.8168914318084717},{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.811903178691864},{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.7761225700378418},{"id":"https://openalex.org/C2910824759","wikidata":"https://www.wikidata.org/wiki/Q6060674","display_name":"Investigational Drugs","level":3,"score":0.5723848342895508},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5383558869361877},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5133587718009949},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5086129903793335},{"id":"https://openalex.org/C2781461381","wikidata":"https://www.wikidata.org/wiki/Q2292945","display_name":"Papillary thyroid cancer","level":4,"score":0.5028347373008728},{"id":"https://openalex.org/C526584372","wikidata":"https://www.wikidata.org/wiki/Q16399","display_name":"Thyroid","level":2,"score":0.4882095158100128},{"id":"https://openalex.org/C2779341817","wikidata":"https://www.wikidata.org/wiki/Q5464665","display_name":"Follicular thyroid cancer","level":5,"score":0.4562036991119385},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4338074326515198},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.42291587591171265},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34810131788253784},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013964","descriptor_name":"Thyroid Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013964","descriptor_name":"Thyroid Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D013964","descriptor_name":"Thyroid Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":1,"locations":[{"id":"pmid:20496261","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20496261","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2019556233","https://openalex.org/W2529925142","https://openalex.org/W7100869910","https://openalex.org/W2147311374","https://openalex.org/W4200071098","https://openalex.org/W2003581503","https://openalex.org/W2027331882","https://openalex.org/W1964562725","https://openalex.org/W2017251306","https://openalex.org/W2150001950"],"abstract_inverted_index":{"The":[0,7],"treatment":[1,32,40,49,83],"of":[2,10,33,41,50,63,75,84,118],"thyroid":[3,14,35,43,52,85],"cancer":[4,53,86],"is":[5],"evolving.":[6],"molecular":[8],"mechanisms":[9],"carcinogenesis":[11],"for":[12,23,81,92],"many":[13],"cancers":[15],"have":[16,20,89,111],"been":[17,90],"investigated,":[18],"and":[19,45,72,105,120],"yielded":[21],"targets":[22,27],"potential":[24],"therapies.":[25],"These":[26],"include":[28],"VEGFR":[29],"in":[30,38,47,94,114,125],"the":[31,39,48,82],"all":[34],"cancers,":[36],"BRAF":[37],"papillary":[42],"cancer,":[44],"RET":[46],"medullary":[51],"(MTC).":[54],"Many":[55],"promising":[56],"drugs":[57],"that":[58],"target":[59],"one":[60],"or":[61],"more":[62],"these":[64],"proteins":[65],"are":[66,77,121],"currently":[67],"being":[68,122],"evaluated,":[69],"including":[70],"sorafenib":[71],"sunitinib,":[73],"both":[74],"which":[76,88],"still":[78],"under":[79],"development":[80],"but":[87],"approved":[91],"use":[93],"other":[95],"malignancies.":[96],"In":[97],"addition,":[98],"compounds":[99],"such":[100],"as":[101],"vandetanib":[102],"(AstraZeneca":[103],"plc)":[104],"XL-184":[106],"(Bristol-Myers":[107],"Squibb":[108],"Co/Exelixis":[109],"Inc)":[110],"demonstrated":[112],"activity":[113],"early-phase":[115],"clinical":[116],"trials":[117],"MTC":[119],"tested":[123],"further":[124],"randomized":[126],"trials.":[127]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}